Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

1.

Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration.

Donati OF, Lakhman Y, Sala E, Burger IA, Vargas HA, Goldman DA, Andikyan V, Park KJ, Chi DS, Hricak H.

Eur Radiol. 2013 Oct;23(10):2906-15. doi: 10.1007/s00330-013-2875-1. Epub 2013 May 8.

PMID:
23652852
[PubMed - indexed for MEDLINE]
2.

Magnetic resonance imaging/positron emission tomography provides a roadmap for surgical planning and serves as a predictive biomarker in patients with recurrent gynecological cancers undergoing pelvic exenteration.

Vargas HA, Burger IA, Donati OF, Andikyan V, Lakhman Y, Goldman DA, Schöder H, Chi DS, Sala E, Hricak H.

Int J Gynecol Cancer. 2013 Oct;23(8):1512-9. doi: 10.1097/IGC.0b013e3182a41e61.

PMID:
24257566
[PubMed - indexed for MEDLINE]
3.

The value of 18F-FDG PET/CT in recurrent gynecologic malignancies prior to pelvic exenteration.

Burger IA, Vargas HA, Donati OF, Andikyan V, Sala E, Gonen M, Goldman DA, Chi DS, Schöder H, Hricak H.

Gynecol Oncol. 2013 Jun;129(3):586-92. doi: 10.1016/j.ygyno.2013.01.017. Epub 2013 Jan 29.

PMID:
23369941
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Pelvic exenteration for primary and recurrent gynaecological malignancies.

de Wilt JH, van Leeuwen DH, Logmans A, Verhoef C, Kirkels WJ, Vermaas M, Ansink AC.

Eur J Obstet Gynecol Reprod Biol. 2007 Oct;134(2):243-8. Epub 2006 Sep 6.

PMID:
16950559
[PubMed - indexed for MEDLINE]
5.

The role of MR imaging in determining surgical eligibility for pelvic exenteration.

Popovich MJ, Hricak H, Sugimura K, Stern JL.

AJR Am J Roentgenol. 1993 Mar;160(3):525-31.

PMID:
8430546
[PubMed - indexed for MEDLINE]
6.

Prognostic factors in pelvic exenteration for gynecological malignancies.

Baiocchi G, Guimaraes GC, Rosa Oliveira RA, Kumagai LY, Faloppa CC, Aguiar S, Begnami MD, Soares FA, Lopes A.

Eur J Surg Oncol. 2012 Oct;38(10):948-54. doi: 10.1016/j.ejso.2012.07.002. Epub 2012 Jul 18.

PMID:
22818842
[PubMed - indexed for MEDLINE]
7.

Surgical salvage of recurrent rectal cancer after transanal excision.

Weiser MR, Landmann RG, Wong WD, Shia J, Guillem JG, Temple LK, Minsky BD, Cohen AM, Paty PB.

Dis Colon Rectum. 2005 Jun;48(6):1169-75.

PMID:
15793645
[PubMed - indexed for MEDLINE]
8.

Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.

Fleisch MC, Pantke P, Beckmann MW, Schnuerch HG, Ackermann R, Grimm MO, Bender HG, Dall P.

J Surg Oncol. 2007 May 1;95(6):476-84.

PMID:
17192947
[PubMed - indexed for MEDLINE]
9.

Characteristics of gynecologic oncology patients in King Chulalongkorn Memorial Hospital - complications and outcome of pelvic exenteration.

Oranratanaphan S, Termrungruanglert W, Sirisabya N.

Asian Pac J Cancer Prev. 2013;14(4):2529-32.

PMID:
23725169
[PubMed - indexed for MEDLINE]
Free Article
10.

Pelvic exenterations for gynecological malignancies: a study of 36 cases.

Kaur M, Joniau S, D'Hoore A, Van Calster B, Van Limbergen E, Leunen K, Penninckx F, Van Poppel H, Amant F, Vergote I.

Int J Gynecol Cancer. 2012 Jun;22(5):889-96. doi: 10.1097/IGC.0b013e31824eb8cd.

PMID:
22617477
[PubMed - indexed for MEDLINE]
11.

Total pelvic exenteration for primary and recurrent malignancies.

Ferenschild FT, Vermaas M, Verhoef C, Ansink AC, Kirkels WJ, Eggermont AM, de Wilt JH.

World J Surg. 2009 Jul;33(7):1502-8. doi: 10.1007/s00268-009-0066-7.

PMID:
19421811
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Mesorectal lymph node involvement and prognostic implications at total pelvic exenteration for gynecologic malignancies.

Mourton SM, Chi DS, Sonoda Y, Alektiar KM, Venkatraman ES, Barakat RR, Abu-Rustum NR.

Gynecol Oncol. 2006 Mar;100(3):533-6. Epub 2005 Oct 14.

PMID:
16226800
[PubMed - indexed for MEDLINE]
13.

The role of pelvic exenteration and reconstruction for treatment of advanced or recurrent gynecologic malignancies: Analysis of risk factors predicting recurrence and survival.

Park JY, Choi HJ, Jeong SY, Chung J, Park JK, Park SY.

J Surg Oncol. 2007 Dec 1;96(7):560-8.

PMID:
17708548
[PubMed - indexed for MEDLINE]
14.

Preoperative assessment of complete tumour resection by magnetic resonance imaging in patients undergoing pelvic exenteration.

Forner DM, Meyer A, Lampe B.

Eur J Obstet Gynecol Reprod Biol. 2010 Feb;148(2):182-5. doi: 10.1016/j.ejogrb.2009.10.022. Epub 2009 Nov 17.

PMID:
19919889
[PubMed - indexed for MEDLINE]
15.

Overall survival after pelvic exenteration for gynecologic malignancy.

Westin SN, Rallapalli V, Fellman B, Urbauer DL, Pal N, Frumovitz MM, Ramondetta LM, Bodurka DC, Ramirez PT, Soliman PT.

Gynecol Oncol. 2014 Sep;134(3):546-51. doi: 10.1016/j.ygyno.2014.06.034. Epub 2014 Jul 9.

PMID:
25014540
[PubMed - indexed for MEDLINE]
16.

Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall.

Höckel M, Sclenger K, Hamm H, Knapstein PG, Hohenfellner R, Rösler HP.

Cancer. 1996 May 1;77(9):1918-33.

PMID:
8646694
[PubMed - indexed for MEDLINE]
17.

Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.

Jäger L, Nilsson PJ, Rådestad AF.

Int J Gynecol Cancer. 2013 May;23(4):755-62. doi: 10.1097/IGC.0b013e318287a874. Review.

PMID:
23407096
[PubMed - indexed for MEDLINE]
18.

Feasibility of adjuvant chemotherapy after pelvic exenteration for gynecologic malignancies.

Andikyan V, Khoury-Collado F, Sandadi S, Tew WP, O'Cearbhaill RE, Konner JA, Sonoda Y, Barakat RR, Chi DS, Abu-Rustum NR.

Int J Gynecol Cancer. 2013 Jun;23(5):923-8. doi: 10.1097/IGC.0b013e318290ea8f.

PMID:
23698798
[PubMed - indexed for MEDLINE]
19.

A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration.

Husain A, Akhurst T, Larson S, Alektiar K, Barakat RR, Chi DS.

Gynecol Oncol. 2007 Jul;106(1):177-80. Epub 2007 May 2.

PMID:
17477959
[PubMed - indexed for MEDLINE]
20.

Pelvic exenteration: long-term oncological results in a series of 106 patients.

De Wever I.

Acta Chir Belg. 2011 Sep-Oct;111(5):282-7.

PMID:
22191128
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk